SIMPLY BETTER STRAUMANN SLActive
SLActive 1 SLActive SLA SLActive SLA 2,3,4,5,6,7 SLActive 1,3,4,5,6,7,8,9 3 4 2 8 SLActive SLA SLActive SLA 1 2 3 4 5 6 7 8
1,2 SLActive 2 2 4 1 SLActive SLA SLActive 11 SLActive SLA BIC SLActive 2 4 *p<.5 7 6 5 4 3 2 1 1 2 3 4 5 6 SLActive SLA SLActive Lai 12 A. B. 1 8 SLActive SLA 6 4 2 2 4 A. 2 4 BIC 2 SLActive *p<.5 B. Clinical Oral Implants Research
13,14 SLActive SLActive SLA SLActive SLActive SLA 12 SLActive SLA SLActive BIC 8% SLA BIC 5%
歯槽骨頂維持による高い信頼性8 高いインプラント成功率が最も重要です SLActive はより高い安全性をもたらすよう設計されており 治療の早期段階におけ る高い予知性が治療結果に対する確信を高めます Straumann SLActive インプラ ントを用いた早期荷重では 3 年後の生存率が96.7%という優れた結果を示していま 8 す 2. 早期荷重 歯槽頂骨の変化 mm 1.8 1.6 1.4 1.2 1..8.6.4.2 5 1 15 2 25 3 35 4 時間 月 インプラント埋入から3 年間の定期検診での SLActive インターフェイスの歯槽頂骨の変化を示す 骨頂レベ ルは インプラント埋入時から有意な変化は認められない
References 1 Bornstein MM, Wittneben JG, Brägger U, Buser D. Early loading at 21 days of non-submerged titanium implants with a chemically modified sandblasted and acid-etched surface: 3-year results of a prospective study in the posterior mandible. J. Periodontol. 21 Jun;81(6):89 18. 2 Oates TW, Valderrama P, Bischof M, Nedir R, Jones A, Simpson J, Toutenburg H, Cochran DL. Enhanced implant stability with a chemically modified SLA surface: a randomized pilot study. Int. J. Oral Maxillofac. Implants. 27;22(5):755 76. 3 Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Bone regeneration in dehiscence-type defects at chemically modified (SLActive) and conventional SLA titanium implants: A pilot study in dogs. J. Clin. Periodontol. 27;34(1):78 86. 4 Schwarz F, Ferrari D, Herten M, Mihatovic I, Wieland M, Sager M, Becker J. Effects of surface hydrophilicity and microtopography on early stages of soft and hard tissue integration at non-submerged titanium implants: An immunohistochemical study in dogs. J. Periodontol. 27;78(11):2171 2184. 5 Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA titanium implants. A pilot study in dogs. Clin. Oral Impl. Res. 27;11(3):245 455. 6 Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA titanium implants: Preliminary results of a pilot study in dogs. Clin. Oral Impl. Res. 27;11(4):481 488. 7 Buser D, Broggini N, Wieland M, Schenk RK, Denzer AJ, Cochran DL, Hoffmann B, Lussi A, Steinemann SG. Enhanced bone apposition to a chemically modified SLA titanium surface. J. Dent. Res. 24 Jul;83(7):529 33. 8 Nicolau, P., et al., Immediate and early loading of chemically modified implants in posterior jaws: 3-year results from a prospective randomised multicenter study Clin Implant Dent Relat Res. 211 Dec 15. doi: 1.1111/j.178-828.211.418.x. [Epub ahead of print] 9 Luongo G, Oteri G. A noninterventional study documenting use and success of implants with a new chemically modified titanium surface in daily dental practice. J. Oral Implantol. 21;36(4):35 14. 1 Raghavendra S, Wood MC, Taylor TD. Int. J. Oral Maxillofac. Implants. 25 May Jun;2(3):425 31. 11 Lang, N. P., et al., Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin Oral Implants. Res 22.4 (211): 349 56. 12 Lai HC, Zhuang LF, Zhang ZY, Wieland M, Liu X. Bone apposition around two different sandblasted, large-grit and acid-etched implant surfaces at sites with coronal circumferential defects: An experimental study in dogs. Clin. Oral Impl. Res. 29;2(3):247 53. 13 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive ) and conventional SLA titanium implants: a pilot study in dogs. J Clin.Periodontol. 34.1 (27): 78 86 14 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive ) and conventional SLA titanium implants: an immunohistochemical study in dogs. J Clin.Periodontol. 35.1 (28): 64 75. www.straumann.jp SLActive TL 226BZX16 1-5 1-7-12 16 TEL.12-418-995 FAX.12-418-89 TEL 9 17 3 JPC25/214.2 5K MP Institut Straumann AG Straumann Straumann Straumann Holdings AG